Dr. Jasmin Rahhal-Schupp

I have been working in the practice since 2019. Here you can find out more about my education, additional qualifications, and personal information about me.

Education Switzerland & Austria

  • 1999 Matura in Vienna
  • 1999/2000 start of medical studies at the University of Vienna
  • 2007 Graduation Medial Studies
  • 2008 Assistant doctor for gynecology and obstetrics, Oberengadin Hospital in Switzerland, Samedan
  • 2009 resident doctor, Sisters of Mercy Vienna
  • 2009- 2012 Research Associate at the University Hospital Vienna, Department of Gynecological Oncology
  • 2010-2012 Assistant doctor for gynaecology, Vienna General Hospital
  • 2013 Assistant doctor for surgery, Sisters of Mercy Vienna
  • 2013-2014 Assistant doctor for gynaecology, St. Josef Hospital Vienna – Department of breast surgery
  • 2015-2016 maternity leave
  • 2016 Resident doctor, Tulln Hospital – Paediatrics
  • 2017 Obtaining the specialist diploma for gynecology and obstetrics
  • 2017 Establishment of the breast health center in the St. Josef Hospital and work as a specialist Gynecologist
  • 2017-1018 Specialist Gynacologist, Wilhelminenspital Vienna

Additional education and training

  • 2017 diploma course in genetics of the Austrian Medical Association
  • 2017 Additional training in the field of oncological breast surgery, Graz University Hospital
  • 2015- 2016 Laparoscopy courses in the field of gynecology in Switzerland and Austria
  • 2015 Diploma in colposcopy, working group for cervical pathology and colposcopy, Germany
  • 2009-2017 constant ultrasound training in the field of gynecology and obstetrics in Switzerland, Austria and Germany
  • 2010- 2017 annual participation in training courses at the annual congress of gynecology and obstetrics


  • 2017-2018 Lecturer at Sigmund Freud University Vienna


  • OEGGG – Austrian Society for Gynecology & Obstetrics
  • AGO – working group for gynecological oncology
  • Austrian working group for urogynaecology and pelvic floor surgery

Lectures and presentations

  • Accuracy of frozen section diagnostics in assessing the lymph node status of patients with invasive cervical cancer (AGO Austria, Salzburg)
  • Prognostic significance of the serum marker gamma-glutamyl transferase in patients with vulvar carcinoma
    (AGO Austria, Salzburg)
    April 2012
  • Treatment of cervical intraepithelial neoplasia with topical imiquimod
    (American Society of Clinical Oncology, Chicago)
    June 2012
  • Gamma-glutamyltransferase and the prognostic significance of cervical carcinoma (AGO Austria, Salzburg)
    May 2011
  • Association between interleukin-1 and -6 gene polymorphisms and the risk of CIN
    (AGO Austria, Salzburg)
    May 2010
  • The inflammation based Glasgow Prognostic Score predicts survival in patients with cervical cancer
    (European Society of Gynecological Oncology, Belgrade)
    Sep 2009

About me

I have been married since 2011 and am now a mother of three wonderful children.

I value respectful and honest communication in both my professional and private life and I try to put this into practice every day.

In the case of patients, I am particularly concerned with the clarification and accurate communication of medical information because I believe that only those who feel well informed can be treated in a relaxed and calm manner.

In addition to my professional work as a doctor, I love to travel. In 2018 I spent a year exploring the four corners of the world with my then 3-year-old daughter and husband.


  • Relevance of gamma-glutamyltransferase – a marker for apoptoticn balance – in predicting tumor stage and prognosis in vulvar cancer
    Rahhal J, Grimm C, Natter C, Pils S, Speiser P, Joura E, Reinthaller A, Polterauer S.
    Gynecol Oncol , submitted for publication.
  • Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multicenter trial
    Seebacher V, Polterauer S, Grimm C, Rahhal J, Hofstetter G, Bauer EM, Husslein H, Leipold H, Marth C, Reinthaller A, Concin N.
    Br J Cancer, 2012 Apr. 24,106(9): 1551-5. Epub 2012 Feb 7.
  • Relevance of gamma-glutamyltransferase – a marker for apoptotic balance – in predicting tumor stage and prognosis in cervical cancer
    Polterauer S, Hofstetter G, Grimm C, Rahhal J, Mailath-Pokorny M, Kohl M, Concin N, Tempfer C, Marth C, Reinthaller A.
    Gynecol Oncol. 2011 Sep;122(3):590-4. Epub 2011 Jun 12.
  • Vascular endothelial growth factor gene polymorphisms and risk of cervical intraepithelial neoplasia
    Grimm C, Watrowski R, Polterauer S, Baumühlner K, Natter C, Rahhal J, Heinze G, Schuster E, Hefler L, Reinthaller A.
    Int J Gynecol Cancer. 2011 May;21(4):597-601
  • The inflammation-based Glasgow Prognostic Score predicts survival in patients with cervical cancer
    Polterauer S, Grimm C, Seebacher V, Rahhal J, Tempfer C, Reinthaller A, Hefler L.
    Int J Gynecol Cancer. 2010 Aug;20(6):1052-7
  • The impact of lymph node density on survival of cervical cancer patients
    Polterauer S, Hefler L, Seebacher V, Rahhal J, Tempfer C, Horvat R, Reinthaller A, Grimm C.
    Br J Cancer. 2010 Aug 24;103(5):613-6. Epub 2010 Jul 13


Univ. Prof. Dr. Paul Speiser
Dr. Birgit Stihsen
Marion Hirsch and Christine Lötveith